Profiel
Carole Monterrat worked as the Chief Financial Officer at Sopartec SA from 2014 to 2018 and as the Vice President-Resources at PROMETHERA Biosciences SA from 2009 to 2014.
She holds a doctorate from Université de Bordeaux and an MBA from Université Catholique de Louvain, which she received in 2008.
Eerdere bekende functies van Carole Monterrat
| Bedrijven | Functie | Einde |
|---|---|---|
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Financieel Directeur/CFO | 01-09-2018 |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Corporate Officer/Principal | 01-03-2014 |
Opleiding van Carole Monterrat
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Sopartec SA
Sopartec SA Investment ManagersFinance Sopartec invests in companies located in Europe. The firm focuses on sectors such as life sciences, AgTech and hard engineering. It participates in seed, early and growth stage capital transactions with an investment size of EUR 0.1 - 7 million. The firm also acts as lead investor. | Finance |
Université de Bordeaux
Université de Bordeaux Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Catholique de Louvain
Université Catholique de Louvain Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PROMETHERA Biosciences SA
PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes cell therapy products to treat liver diseases | Health Technology |
















